Advertisement

Hysterectomy pp 429-466 | Cite as

Uterine-Preserving Operative Therapy of Uterus Myomatosus

  • Andrea TinelliEmail author
  • Ospan A. Mynbaev
  • Daniele Vergara
  • Silvia Di Tommaso
  • Sandro Gerli
  • Alessandro Favilli
  • Ivan Mazzon
  • Radmila Sparic
  • Marina Eliseeva
  • Sergei S. Simakov
  • Alexander A. Danilov
  • Antonio Malvasi
Chapter

Abstract

Uterine myomas are the most frequent benign tumours of the uterus in women of childbearing age. Although uterine fibroids cause symptoms in only 20–50 % of cases, if present they may cause abnormal uterine bleeding, pain, and infertility.

The advent of modern endoscopy offers a valid minimally invasive alternative approach, avoiding radical treatment such as hysterectomy. Nevertheless, over the years complications due to the use of electricity during myomectomy have been highlighted. The concept of possible negative effects on fertility and pregnancy outcome due to the use of intraoperative monopolar or bipolar coagulation has been clearly demonstrated. Damage to the surrounding healthy myometrium after laparoscopic myomectomy is considered the major risk factor for uterine rupture in pregnancy. However, monopolar and bipolar coagulation are still widely used in clinical practice during myomectomy.

In the last decade numerous studies have been conducted on uterine myomas and new anatomical and physiopathological knowledge has come to light. Particular attention has been paid to the structure surrounding the myoma and its role on myometrial healing: the pseudocapsule. A neuro-biological property of myoma pseudocapsule was recently demonstrated as the vascular structure has specific characteristics similar to those of cancer.

For many years, surgeons have paid no attention to the presence of fibroid pseudocapsule during the myomectomy, probably due to underestimate of its functionality. The new knowledge on the myoma pseudocapsule confirms the importance of myometrial sparing during myomectomy and the advantages offered by the “cold surgery”.

These issues open new perspectives on treatment of uterine myomas and are of great mportance for fertility patients.

Keywords

Laparoscopic Myomectomy Pseudocapsule (PC) Leiomyoma Uterine Fibroids Cold Loop 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

Notes

Acknowledgement

This work was supported by the Russian Science Foundation (grant 14-31-00,024). Some authors are members of the International Translational Medicine and Biomodeling Research Team (http://mathbiomed.crec.mipt.ru).

References

  1. 1.
    Tomasik P, Bomba-Opon D, Krupniewski L, Palczewski P, Wielgos M. Evaluation of uterine myomas during pregnancy using magnetic resonance imaging. Neuro Endocrinol Lett. 2014;35(4):262–4.PubMedGoogle Scholar
  2. 2.
    Downes E, Sikirica V, Gilabert-Estelles J, Bolge SC, Dodd SL, Maroulis C, et al. The burden of uterine fibroids in five European countries. Eur J Obstet Gynecol Reprod Biol. 2010;152(1):96–102.PubMedCrossRefGoogle Scholar
  3. 3.
    Baskett TF. Hysterectomy: evolution and trends. Best Pract Res Clin Obstet Gynaecol. 2005;19(3):295–305.PubMedCrossRefGoogle Scholar
  4. 4.
    Fleischer R, Weston GC, Vollenhoven BJ, Rogers PA. Pathophysiology of fibroid disease: angiogenesis and regulation of smooth muscle proliferation. Best Pract Res Obstet Gynaecol. 2008;22(4):603–14.CrossRefGoogle Scholar
  5. 5.
    Okolo S. Incidence, aetiology and epidemiology of uterine fibroids. Best Pract Res Obstet Gynaecol. 2008;22(4):571–88.CrossRefGoogle Scholar
  6. 6.
    Tinelli A, Malvasi A, Rahimi S, Negro R, Cavallotti C, Vergara D, Vittori G, Mettler L. Myoma pseudocapsule: a distinct endocrino-anatomical entity in gynecological surgery. Gynecol Endocrinol. 2009;25(10):661–7.PubMedCrossRefGoogle Scholar
  7. 7.
    Tinelli A, Hurst BS, Hudelist G, Tsin DA, Stark M, Mettler L, Guido M, Malvasi A. Laparoscopic myomectomy focusing on the myoma pseudocapsule: technical and outcome reports. Hum Reprod. 2012;27(2):427–35.PubMedCrossRefGoogle Scholar
  8. 8.
    Evans P, Brunsell S. Uterine fibroid tumors: diagnosis and treatment. Am Fam Physician. 2007;75(10):1503–8.PubMedGoogle Scholar
  9. 9.
    Somigliana E, Vercellini P, Daguati R, Pasin R, De Giorgi O, Crosignani PG. Fibroids and female reproduction: a critical analysis of the evidence. Hum Reprod Update. 2007;13(5):465–76.PubMedCrossRefGoogle Scholar
  10. 10.
    Wise LA, Laughlin-Tommaso SK. Uterine leiomyomata. In: Goldman MB, Troisi R, Rexrode KM, editors. Women and health. San Diego: Academic; 2013. p. 285–306.CrossRefGoogle Scholar
  11. 11.
    Graff-Radford J, Jones DT, Pruthi RK, Flemming KD. A neurological complication of a uterine fibroid. Neurocrit Care. 2013;18(1):93–5.PubMedCrossRefGoogle Scholar
  12. 12.
    Wise LA, Palmer JR, Harlow BL, Spiegelman D, Stewart EA, Adams-Campbell LL, et al. Reproductive factors, hormonal contraception and risk of uterine leiomyomata in African-American women: a prospective study. Am J Epidemiol. 2004;159(2):113–23.PubMedPubMedCentralCrossRefGoogle Scholar
  13. 13.
    Laughlin SK, Baird DD, Savitz DA, Herring AH, Hartmann KE. Prevalence of uterine leiomyomas in the first trimester of pregnancy. Obstet Gynecol. 2009;113(3):630–5.PubMedPubMedCentralCrossRefGoogle Scholar
  14. 14.
    Wise LA, Ruiz-Narvaez EA, Palmer JR, Cozier YC, Tandon A, Patterson N, et al. African ancestry and genetic risk for uterine leiomyomata. Am J Epidemiol. 2012;176(12):1159–68.PubMedPubMedCentralCrossRefGoogle Scholar
  15. 15.
    Okogbo FO, Ezechi OC, Loto OM, Ezeobi PM. Uterine leiomyomata in South Western Nigeria: a clinical study of presentations and management outcome. Afr Health Sci. 2011;11(2):271–8.PubMedPubMedCentralGoogle Scholar
  16. 16.
    Gupta S, Jose J, Mayonda I. Clinical presentation of fibroids. Best Pract Res Clin Obstet Gynaecol. 2008;22(4):615–26.PubMedCrossRefGoogle Scholar
  17. 17.
    Sparić R, Hudelist G, Berisavac M, Gudović A, Buzadžić S. Hysterectomy throughout history. Acta Chir Iugosl. 2011;58(4):9–14.PubMedCrossRefGoogle Scholar
  18. 18.
    Tinelli A, Hurst SB, Mettler L, Tsin AD, Pellegrino M, Nicolardi G, Dell’Edera D, Malvasi A. Ultrasound evaluation of uterine healing after laparoscopic intracapsular myomectomy: an observational study. Hum Reprod. 2012;27(9):2664–70.PubMedCrossRefGoogle Scholar
  19. 19.
    Divakar H. Asymptomatic uterine fibroids. Best Pract Res Clin Obstet Gynaecol. 2008;22(4):643–54.PubMedCrossRefGoogle Scholar
  20. 20.
    Cramer SF, Patel A. The frequency of uterine leiomyomas. Am J Clin Pathol. 1990;94(4):435–8.PubMedCrossRefGoogle Scholar
  21. 21.
    Ezeama C, Ikechebelu J, Obiechina NJ, Ezeama N. Clinical presentation of uterine fibroids in Nnewi, Nigeria: a 5-year review. Ann Med Health Sci Res. 2012;2(2):114–8.PubMedPubMedCentralCrossRefGoogle Scholar
  22. 22.
    Stewart EA. Uterine fibroids. Lancet. 2001;357(9252):293–8.PubMedCrossRefGoogle Scholar
  23. 23.
    Kwon DH, Song JE, Yoon KR, Lee KY. The safety of cesarean myomectomy in women with large myomas. Obstet Gynecol Sci. 2014;57(5):367–72.PubMedPubMedCentralCrossRefGoogle Scholar
  24. 24.
    Barlin JN, Giuntoli 2nd RL. Management of uterine leiomyosarcoma: an update. Exp Rev Obstet Gynecol. 2009;4(5):509–20.CrossRefGoogle Scholar
  25. 25.
    Parker WH, Fu YS, Berek JS. Uterine sarcoma in patients operated on for presumed leiomyoma and rapidly growing leiomyoma. Obstet Gynecol. 1994;83(3):414–8.PubMedGoogle Scholar
  26. 26.
    Hyman DM, Grisham RN, Hensley ML. Management of advanced uterine leiomyosarcoma. Curr Opin Oncol. 2014;26(4):422–7.PubMedCrossRefGoogle Scholar
  27. 27.
    Indraccolo U, Luchetti G, Indraccolo SR. Malignant transformation of uterine leiomyomata. Eur J Gynaecol Oncol. 2008;29(5):543–4.PubMedGoogle Scholar
  28. 28.
    Mayerhofer K, Obermair A, Windbichler G, Petru E, Kaider A, Hefler L, et al. Leiomyosarcoma of the uterus: a clinicopathologic multicenter study of 71 cases. Gynecol Oncol. 1999;74(2):196–201.PubMedCrossRefGoogle Scholar
  29. 29.
    Leibsohn S, d’Ablaing G, Mishell Jr DR, Schalaerth JB. Leiomyosarcoma in a series of hysterectomies performed for presumed uterine leiomyomas. Am J Obstet Gynecol. 1990;162(4):968–76.PubMedCrossRefGoogle Scholar
  30. 30.
    Gockley AA, Rauh-Hain JA, Del Carmen MG. Uterine leiomyosarcoma: a review article. Int J Gynecol Cancer. 2014;24(9):1538–42.PubMedCrossRefGoogle Scholar
  31. 31.
    Bell SW, Kempson RL, Hendrickson MR. Problematic uterine smooth muscle neoplasms: a clinicopathologic study of 213 cases. Am J Surg Pathol. 1994;18:535–58.PubMedCrossRefGoogle Scholar
  32. 32.
    Kobayashi H, Uekuri C, Akasaka J, Ito F, Shigemitsu A, Koike N, Shigetomi H. The biology of uterine sarcomas: a review and update. Mol Clin Oncol. 2013;1(4):599–609.PubMedPubMedCentralCrossRefGoogle Scholar
  33. 33.
    Resta L, Sanguedolce F, Orsini G, Laricchia L, Piscitelli D, Fiore MG. Morphometric and histological evaluation of GnRH agonists or progestational agents-treated uterine leiomyomas. Pathologica. 2004;96:35–41.PubMedGoogle Scholar
  34. 34.
    Sozen I, Arici A. Interactions of cytokines, growth factors, and the extracellular matrix in the cellular biology of uterine leiomyomata. Fertil Steril. 2002;78(1):1–12.PubMedCrossRefGoogle Scholar
  35. 35.
    Bogusiewicz M, Stryjecka-Zimmer M, Postawski K, et al. Activity of matrix metalloproteinase-2 and -9 and contents of their tissue inhibitors in uterine leiomyoma and corresponding myometrium. Gynecol Endocrinol. 2007;23(9):541–6.PubMedCrossRefGoogle Scholar
  36. 36.
    Tinelli A, Malvasi A, Cavallotti C, Dell’Edera D, Tsin DA, Stark M, Mettler L. The management of fibroids based on immunohistochemical studies of their pseudocapsules. Expert Opin Ther Targets. 2011 Nov;15(11):1241–7.PubMedCrossRefGoogle Scholar
  37. 37.
    Tinelli A, Malvasi A, Guido M, Tsin DA, Hudelist G, Hurst B, Stark M, Mettler L. Adhesion formation after intracapsular myomectomy with or without adhesion barrier. Fertil Steril. 2011;95(5):1780–5.PubMedCrossRefGoogle Scholar
  38. 38.
    Faulkner RL. The blood vessels of the myomatous uteri. Am J Obstet Gynaecol. 1944;47:185–97.CrossRefGoogle Scholar
  39. 39.
    Farrer-Brown G, Beilby JOW, Tarbit MH. The vascular patterns in myomatous uteri. J Obstet Gynaecol. 1970;77:967–75.CrossRefGoogle Scholar
  40. 40.
    Awataguchi K. Studies on the angioarchitecture of uterine myoma. Nippon Ika Daigaku Zasshi. 1982;49:225–32.PubMedCrossRefGoogle Scholar
  41. 41.
    Casey R, Rogers PA, Vollenhoven BJ. An immunohystochemical analysis of fibroid vasculature. Hum Reprod. 2000;15(7):1469–75.PubMedCrossRefGoogle Scholar
  42. 42.
    Campo S, Garcea N. Laparoscopic myomectomy in premenopausal women with and without preoperative treatment using gonadotrophin-releasing hormone analogues. Hum Reprod. 1999;14:44–8.PubMedCrossRefGoogle Scholar
  43. 43.
    Lethaby A, Vollenhoven B, Sowter M. Pre-operative Gn-RH analogue therapy before hysterectomy or myomectomy for uterine fibroids. Cochrane Database Syst Rev. 2001;2:CD000547.Google Scholar
  44. 44.
    Pinkerton JV. Pharmacological therapy for abnormal uterine bleeding. Menopause. 2011;18(4):459–67.CrossRefGoogle Scholar
  45. 45.
    Walocha JA, Litwin JA, Miodonski A. Vascular system of intramural leiomyomata revealed by corrosion casting and scanning electron microscopy. Hum Reprod. 2003;18:1088–93.PubMedCrossRefGoogle Scholar
  46. 46.
    Forssman L. Blood flow in myomatous uteri as measured by intraarterial 133-Xenon. Acta Obstet Gynecol Scand. 1976;55:21–4.PubMedCrossRefGoogle Scholar
  47. 47.
    Wei JJ, Zhang XM, Chiriboga L, Yee H, Perle MA, Mittal K. Spatial differences in biologic activity of large uterine leiomyomata. Fertil Steril. 2006;85:179–87.PubMedCrossRefGoogle Scholar
  48. 48.
    Malvasi A, Tinelli A, Cavallotti C, Morroni M, Tsin DA, Nezhat C, et al. Distribution of substance P (SP) and vasoactive intestinal peptide (VIP) in pseudocapsules of uterine fibroids. Peptides. 2011;32:327–32.PubMedCrossRefGoogle Scholar
  49. 49.
    Mettler L, Tinelli A, Hurst BS, Teigland CM, Sammur W, Dell’Edera D, Negro R, Gustapane S, Malvasi A. Neurovascular bundle in fibroid pseudocapsule and its neuroendocrinologic implications. Expert Rev Endocrinol Metab. 2011;6(5):715–22.CrossRefGoogle Scholar
  50. 50.
    Malvasi A, Tinelli A, Rahimi S, D’agnese G, Rotoni C, Dell’Edera D, Tsin DA, Cavallotti C. A three-dimensional morphological reconstruction of uterine leiomyoma pseudocapsule vasculature by the allen-cahn mathematical model. Biomed Pharmacother. 2011;65(5):359–63.PubMedCrossRefGoogle Scholar
  51. 51.
    Malvasi A, Cavallotti C, Morroni M, Lorenzi T, Dell’Edera D, Nicolardi G, Tinelli A. Uterine fibroid pseudocapsule studied by transmission electron microscopy. Eur J Obstet Gynecol Reprod Biol. 2012;162(2):187–91.PubMedCrossRefGoogle Scholar
  52. 52.
    De Falco M, Staibano S, Mascolo M, Mignogna C, Improda L, Ciociola F, Carbone IF, Di Lieto A. Leiomyoma pseudocapsule after pre-surgical treatment with gonadotropin releasing hormone agonists: relationship between clinical features and immunohistochemical changes. Eur J Obstet Gynecol Reprod Biol. 2009;144:44–7.PubMedCrossRefGoogle Scholar
  53. 53.
    Mavrelos D, Ben-Nagi J, Davies A, Lee C, Salim R, Jurkovic D. The value of pre-operative treatment with gnrh analogues in women with submucous fibroids: a double-blind, placebo-controlled randomized trial. Hum Reprod. 2010;25:2264–9.PubMedCrossRefGoogle Scholar
  54. 54.
    Tinelli A, Malvasi A, Cavallotti C, Hudelist G, Tsin DA, Schollmeyer T, Bojahr B, Mettler L. Single and multiple intracapsular laparoscopic myomectomy. an institutional experience. J Laparoendosc Adv Surg Tech A. 2010;20(8):705–11.PubMedCrossRefGoogle Scholar
  55. 55.
    Malvasi A, Cavallotti C, Nicolardi G, Pellegrino M, Dell’edera D, Vergara D, et al. NT, NPY and PGP 9.5 presence in myometrium and in fibroid pseudocapsule and their possible impact on muscular physiology. Gynecol Endocrinol. 2013;29:177–81.Google Scholar
  56. 56.
    Malvasi A, Cavallotti C, Nicolardi G, Pellegrino M, Vergara D, Greco M, et al. The opioid neuropeptides in uterine fibroid pseudocapsules: a putative association with cervical integrity in human reproduction. Gynecol Endocrinol. 2013;29:982–8.PubMedCrossRefGoogle Scholar
  57. 57.
    Gray’s Anatomy. The uterus. In: The anatomical basis of clinical practice. 40th ed., ISBN:978-0-443-06684-9. Churchill-Livingstone, Elsevier, USA; 2008. p. 710–4.Google Scholar
  58. 58.
    Sun Y, Zhu L, Huang X, Zhou C, Zhang X. Immunohistochemical localization of nerve fibers in the pseudocapsule of fibroids. Eur J Histochem. 2014;58(2):2249.PubMedPubMedCentralCrossRefGoogle Scholar
  59. 59.
    Delgado AV, McManus AT, Chambers JP. Exogenous administration of Substance P enhances wound healing in a novel skin-injury model. Exp Biol Med (Maywood). 2005;230:271–80.CrossRefGoogle Scholar
  60. 60.
    Jiang MH, Chung E, Chi GF, Ahn W, Lim JE, Hong HS, et al. Substance P induces M2-type macrophages after spinal cord injury. Neuroreport. 2012;23:786–92.PubMedCrossRefGoogle Scholar
  61. 61.
    Collins JJ, Usip S, McCarson KE, Papka RE. Sensory nerves and neuropeptides in uterine cervical ripening. Peptides. 2002;23:167–83.PubMedCrossRefGoogle Scholar
  62. 62.
    Tingaker BK, Ekman-Ordeberg G, Facer P, Irestedt L, Anand P. Influence of pregnancy and labor on the occurrence of nerve fibers expressing the capsaicin receptor TRPV1 in human corpus and cervix uteri. Reprod Biol Endocrinol. 2008;6:8.PubMedPubMedCentralCrossRefGoogle Scholar
  63. 63.
    Tingaker BK, Ekman-Ordeberg G, Forsgren S. Presence of sensory nerve corpuscles in the human corpus and cervix uteri during pregnancy and labor as revealed by immunohistochemistry. Reprod Biol Endocrinol. 2006;4:45.PubMedPubMedCentralCrossRefGoogle Scholar
  64. 64.
    Cormio L, Gesualdo L, Maiorano E, Bettocchi C, Palumbo F, Traficante A, et al. Vasoactive intestinal polypeptide (VIP) is not an androgen-dependent neuromediator of penile erection. Int J Impot Res. 2005;17:23–6.PubMedCrossRefGoogle Scholar
  65. 65.
    Rodríguez R, Pozuelo JM, Martín R, Arriazu R, Santamaria L. Stereological quantification of nerve fibers immunoreactive to PGP 9.5, NPY, and VIP in rat prostate during postnatal development. J Androl. 2005;26:197–204.PubMedCrossRefGoogle Scholar
  66. 66.
    Arms L, Vizzard MA. Neuropeptides in lower urinary tract function. Handb Exp Pharmacol. 2011;202:395–423.CrossRefGoogle Scholar
  67. 67.
    Merrill L, Girard B, Arms L, Guertin P, Vizzard MA. Neuropeptide/Receptor expression and plasticity in micturition pathways. Curr Pharm Des. 2013;19:4411–22.PubMedCrossRefGoogle Scholar
  68. 68.
    Di Tommaso S, Massari S, Malvasi A, Bozzetti MP, Tinelli A. Gene expression analysis reveals an angiogenic profile in uterine leiomyoma pseudocapsule. Mol Hum Reprod. 2013;19(6):380–7.PubMedCrossRefGoogle Scholar
  69. 69.
    Stewart EA, Nowak RA. Leiomyoma-related bleeding: a classic hypothesis updated for the molecular era. Hum Reprod Update. 1996;2(4):295–306.PubMedCrossRefGoogle Scholar
  70. 70.
    Bulun SE. Uterine fibroids. N Engl J Med. 2013;369:1344–55.PubMedCrossRefGoogle Scholar
  71. 71.
    Di Tommaso S, Massari S, Malvasi A, Vergara D, Maffia M, Greco M, Tinelli A. Selective genetic analysis of myoma pseudocapsule and potential biological impact on uterine fibroid medical therapy. Expert Opin Ther Targets. 2015 Jan;19(1):7–12.PubMedCrossRefGoogle Scholar
  72. 72.
    Mäkinen N, Mehine M, Tolvanen J, et al. MED12, the mediator complex subunit 12 gene, is mutated at high frequency in uterine leiomyomas. Science. 2011;334:252–5.PubMedCrossRefGoogle Scholar
  73. 73.
    Dallas NA, Samuel S, Xia L, et al. Endoglin (CD105): a marker of tumor vasculature and potential target for therapy. Clin Cancer Res. 2008;14:1931–7.PubMedCrossRefGoogle Scholar
  74. 74.
    Valluru M, Brown NJ, Cross SS, et al. Blood vessel characterization in human dermal wound repair and scarring. Br J Dermatol. 2011;165:221–4.PubMedCrossRefGoogle Scholar
  75. 75.
    Di Tommaso S, Tinelli A, Malvasi A, Massari S. Missense mutations in exon 2 of the MED12 gene are involved in IGF-2 overexpression in uterine leiomyoma. Mol Hum Reprod. 2014;20(10):1009–15.PubMedCrossRefGoogle Scholar
  76. 76.
    Tinelli A, Mynbaev OA, Mettler L, Hurst BS, Pellegrino M, Nicolardi G, Kosmas I, Malvasi A. A combined ultrasound and histologic approach for analysis of uterine fibroid pseudocapsule thickness. Reprod Sci. 2014;21(9):1177–86.PubMedCrossRefGoogle Scholar
  77. 77.
    Fraser IS, Critchley HO, Munro MG, Broder M, Writing Group for this Menstrual Agreement Process. A process designed to lead to international agreement on terminologies and definitions used to describe abnormalities of menstrual bleeding. Fertil Steril. 2007;87(3):466–76.PubMedCrossRefGoogle Scholar
  78. 78.
    Mettler L, Schollmeyer T, Tinelli A, Malvasi A, Alkatout I. Complications of uterine fibroids and their management, surgical management of fibroids, laparoscopy and hysteroscopy versus hysterectomy, haemorrhage, adhesions and complications. Obstet Gynecol Int. 2012;2012:791248.PubMedPubMedCentralCrossRefGoogle Scholar
  79. 79.
    Darwish AM, Nasr AM, El-Nashar DA. Evaluation of postmyomectomy uterine scar. J Clin Ultrasound. 2005;33(4):181–6.PubMedCrossRefGoogle Scholar
  80. 80.
    Seinera P, Gaglioti P, Volpi E, Cau MA, Todros T. Ultrasound evaluation of uterine wound healing following laparoscopic myomectomy: preliminary results. Hum Reprod. 1999;14(10):2460–3.PubMedCrossRefGoogle Scholar
  81. 81.
    Beyth Y, Jaffe R, Goldberger S. Uterine remodelling following conservative myomectomy. Ultrasonographic evaluation. Acta Obstet Gynecol Scand. 1992;71(8):632–5.PubMedCrossRefGoogle Scholar
  82. 82.
    Pun TC, Chau MT, Lam C, Tang G, Leong L. Sonographic evaluation of the myomectomy ‘scars’. Acta Obstet Gynecol Scand. 1998;77(2):218–21.PubMedCrossRefGoogle Scholar
  83. 83.
    Hanna KR, Katz AJ. An update on wound healing and the nervous system. Ann Plast Surg. 2011;67(1):49–52.PubMedCrossRefGoogle Scholar
  84. 84.
    Tidball JG. Mechanisms of muscle injury, repair, and regeneration. Compr Physiol. 2011;1(4):2029–62.PubMedGoogle Scholar
  85. 85.
    Järvinen TA, Järvinen TL, Kääriäinen M, Kalimo H, Järvinen M. Muscle injuries: biology and treatment. Am J Sports Med. 2005;33(5):745–64.PubMedCrossRefGoogle Scholar
  86. 86.
    Henderson J, Terenghi G, Ferguson MW. The reinnervation and revascularisation pattern of scarless murine fetal wounds. J Anat. 2011;218(6):660–7.PubMedPubMedCentralCrossRefGoogle Scholar
  87. 87.
    Gouin JP, Carter CS, Pournajafi-Nazarloo H, Glaser R, Malarkey WB, Loving TJ, Stowell J, Kiecolt-Glaser JK. Marital behavior, oxytocin, vasopressin, and wound healing. Psychoneuroendocrinology. 2010;35(7):1082–90.PubMedPubMedCentralCrossRefGoogle Scholar
  88. 88.
    Tinelli A, Malvasi A, Hurst BS, Tsin DA, Davila F, Dominguez G, Dell’Edera D, Cavallotti C, Negro R, Gustapane S, Teigland CM, Mettler L. Surgical management of neurovascular bundle in uterine fibroids pseudocapsule. JSLS. 2012;16:119–29.PubMedPubMedCentralCrossRefGoogle Scholar
  89. 89.
    Vikhareva Osser O, Valentin L. Risk factors for incomplete healing of the uterine incision after caesarean section. BJOG. 2010;117(9):1119–26.PubMedCrossRefGoogle Scholar
  90. 90.
    Han M, Kim C, Mozer P, Schäfer F, Badaan S, Vigaru B, Tseng K, Petrisor D, Trock B, Stoianovici D. Tandem-robot assisted laparoscopic radical prostatectomy to improve the neurovascular bundle visualization: a feasibility study. Urology. 2011;77(2):502–6.PubMedCrossRefGoogle Scholar
  91. 91.
    Walz J, Burnett AL, Costello AJ, Eastham JA, Graefen M, Guillonneau B, Menon M, Montorsi F, Myers RP, Rocco B, Villers A. A critical analysis of the current knowledge of surgical anatomy related to optimization of cancer control and preservation of continence and erection in candidates for radical prostatectomy. Eur Urol. 2010;57(2):179–92.PubMedCrossRefGoogle Scholar
  92. 92.
    Lee SE, Hong SK, Han JH, Han BK, Yu JH, Jeong SJ, Byun SS, Lee HJ. Significance of neurovascular bundle formation observed on preoperative magnetic resonance imaging regarding postoperative erectile function after nerve-sparing radical retropubic prostatectomy. Urology. 2007;69(3):510–4.PubMedCrossRefGoogle Scholar
  93. 93.
    Ong AM, Su LM, Varkarakis I, Inagaki T, Link RE, Bhayani SB, Patriciu A, Crain B, Walsh PC. Nerve sparing radical prostatectomy: effects of hemostatic energy sources on the recovery of cavernous nerve function in a canine model. J Urol. 2004;172(4 Pt 1):1318–22.PubMedCrossRefGoogle Scholar
  94. 94.
    Hurst BS. Uterine fibroids. In: Stadtmauer LA, Tur-Kaspa I, editors. Ultrasound imaging in reproductive medicine. New York: Springer; 2014 . p. 117–31.Chapter 10CrossRefGoogle Scholar
  95. 95.
    Falcone T, Parker WH. Surgical management of leiomyomas for fertility or uterine preservation. Obstet Gynecol. 2013;121(4):856–68.PubMedCrossRefGoogle Scholar
  96. 96.
    Tinelli A, Mettler L, Malvasi A, Hurst B, Catherino W, Mynbaev OA, Guido M, Alkatout I, Schollmeyer T. Impact of surgical approach on blood loss during intracapsular myomectomy. Minim Invasive Ther Allied Technol. 2014;23(2):87–95.PubMedCrossRefGoogle Scholar
  97. 97.
    Novak ER, Woodruff JD. Myoma and other benign tumours of the uterus, Novaks’ gynecologic and obstetric pathology with clinical and endocrine relations. Philadelphia: WB Saunders; 1979. p. 795–801.Google Scholar
  98. 98.
    Ouyang DW. Obstetric complications of fibroids. Obstet Gynecol Clin North Am. 2006;33:153–69.PubMedCrossRefGoogle Scholar
  99. 99.
    Song D, Zhang W, Chames MC, Guo J. Myomectomy during cesarean delivery. Int J Gynaecol Obstet. 2013;121(3):208–13.PubMedCrossRefGoogle Scholar
  100. 100.
    Rice JP, Kay HH, Mahony BS. The clinical significance of uterine leiomyomas in pregnancy. Am J Obstet Gynecol. 1989;160:1212–6.PubMedCrossRefGoogle Scholar
  101. 101.
    Exacoustos C, Rosati P. Ultrasound diagnosis of uterine myomas and complications in pregnancy. Obstet Gynecol. 1993;82:97–101.PubMedGoogle Scholar
  102. 102.
    Katz VL, Dotters DJ, Droegemueller W. Complications of uterine leiomyomas in pregnancy. Obstet Gynecol. 1989;73:593–6.PubMedGoogle Scholar
  103. 103.
    Incebiyik A, Hilali NG, Camuzcuoglu A, Vural M, Camuzcuoglu H. Myomectomy during caesarean: a retrospective evaluation of 16 cases. Arch Gynecol Obstet. 2014;289(3):569–73.PubMedCrossRefGoogle Scholar
  104. 104.
    Hasan F, Arumugam K, Sivanesaratnam V. Uterine leiomyomata in pregnancy. Int J Gynaecol Obstet. 1991;34:45–8.PubMedCrossRefGoogle Scholar
  105. 105.
    Vergani P, Locatelli A, Ghidini A, Andreani M, Sala F, Pezzullo JC. Large uterine leiomyomata and risk of cesarean delivery. Obstet Gynecol. 2007;109:410–4.PubMedCrossRefGoogle Scholar
  106. 106.
    Coronado GD, Marshall LM, Schwartz SM. Complications in pregnancy, labor, and delivery with uterine leiomyomas: a population-based study. Obstet Gynecol. 2000;95:764–9.PubMedGoogle Scholar
  107. 107.
    Cunningham FG, Leveno KL, Bloom SL, Hauth JC, Gilstrap III LC, Wenstrom KD, editors. Abnormalities of the reproductive tract. In Williams obstetrics. 22st ed. New York: Mcgraw-Hill Medical Publishing Division; 2005.Google Scholar
  108. 108.
    Ludmir J, Stubblefield PG. Surgical procedures in pregnancy. In: Gabbe SG, Niebyl JR, Simpson JL, editors. Gabbe: obstetrics-normal and problem pregnancies. 4th ed. New York: Churchill Livingstone, Inc.; 2002. p. 613.Google Scholar
  109. 109.
    Tinelli A, Malvasi A, Mynbaev OA, Barbera A, Perrone E, Guido M, Kosmas I, Stark M. The surgical outcome of intracapsular cesarean myomectomy. A match control study. J Matern Fetal Neonatal Med. 2014;27(1):66–71.PubMedCrossRefGoogle Scholar
  110. 110.
    Neuwirth RS, Amin HK. Excision of submucus fibroids with hysteroscopic control. Am J Obstet Gynecol. 1976;126:95–9.PubMedCrossRefGoogle Scholar
  111. 111.
    Di Spiezio Sardo A, Mazzon I, Bramante S, Bettocchi S, Bifulco G, Guida M, Nappi C. Hysteroscopic myomectomy: a comprehensive review of surgical techniques. Hum Reprod Update. 2008;14:101–19.PubMedCrossRefGoogle Scholar
  112. 112.
    Jedeikin R, Olsfanger D, Kessler I. Disseminated intravascular coagulopathy and adult respiratory distress syndrome: life-threatening complications of hysteroscopy. Am J Obstet Gynecol. 1990;162:44–5.PubMedCrossRefGoogle Scholar
  113. 113.
    Sullivan B, Kenney P, Seibel M. Hysteroscopic resection of fibroid with thermal injury to sigmoid. Obstet Gynecol. 1992;80:546–7.PubMedGoogle Scholar
  114. 114.
    Howe RS. Third-trimester uterine rupture following hysteroscopic uterine perforation. Obstet Gynecol. 1993;81:827–9.PubMedGoogle Scholar
  115. 115.
    Murakami T, Tamura M, Ozawa Y, Suzuki H, Terada Y, Okamura K. Safe techniques in surgery for hysteroscopic myomectomy. J Obstet Gynaecol Res. 2005 Jun;31(3):216–23.PubMedCrossRefGoogle Scholar
  116. 116.
    Mazzon I, Favilli A, Cocco P, Grasso M, Horvath S, Bini V, Di Renzo GC, Gerli S. Does cold loop hysteroscopic myomectomy reduce intrauterine adhesions? A retrospective study. Fertil Steril. 2014;101:294–298.e3.PubMedCrossRefGoogle Scholar
  117. 117.
    Mazzon I. Nuova tecnica per la miomectomia isteroscopica: enucleazione con ansa fredda. In: Cittadini E, Perino A, Angiolillo M, Minelli L, editors. Testo-Atlante di Chirurgia Endoscopica Ginecologica. Palermo: COFESE; 1995 .chapt XXXIIIbGoogle Scholar
  118. 118.
    Zhao X, Zeng W, Chen L, Chen L, Du W, Yan X. Laparoscopic myomectomy using “cold” surgical instruments for uterine corpus leiomyoma: a preliminary report. Cell Biochem Biophys. 2014;72:141–6. [Epub ahead of print]CrossRefGoogle Scholar
  119. 119.
    Wamsteker K, Emanuel MH, de Kruif JH. Transcervical hysteroscopic resection of submucous fibroids for abnormal uterine bleeding: results regarding the degree of intramural extension. Obstet Gynecol. 1993;82:736–40.PubMedGoogle Scholar
  120. 120.
    Emanuel MH, Wamsteker K, Hart AA, Metz G, Lammes FB. Long-term results of hysteroscopic myomectomy for abnormal uterine bleeding. Obstet Gynecol. 1999;93:743–8.PubMedGoogle Scholar
  121. 121.
    Lasmar RB, Barrozo PR, Dias R, Oliveira MA. Submucous myomas: a new presurgical classification to evaluate the viability of hysteroscopic surgical treatment-preliminary report. J Minim Invasive Gynecol. 2005;12:308–11.PubMedCrossRefGoogle Scholar
  122. 122.
    Casadio P, Youssef AM, Spagnolo E, Rizzo MA, Talamo MR, De Angelis D, Marra E, Ghi T, Savelli L, Farina A, Pelusi G, Mazzon I. Should the myometrial free margin still be considered a limiting factor for hysteroscopic resection of submucous fibroids? A possible answer to an old question. Fertil Steril. 2011;95:1764–8.e1.PubMedCrossRefGoogle Scholar
  123. 123.
    Jansen FW, Vredevoogd CB, van Ulzen K, Hermans J, Trimbos JB, Trimbos-Kemper TC. Complications of hysteroscopy: a prospective, multicenter study. Obstet Gynecol. 2000;96:266–70.PubMedGoogle Scholar
  124. 124.
    Hallez JP. Single-stage total hysteroscopic myomectomies: indications, techniques, and results. Fertil Steril. 1995;63:703–8.PubMedCrossRefGoogle Scholar
  125. 125.
    Aydeniz B, Gruber IV, Schauf B, Kurek R, Meyer A, Wallwiener D. A multicenter survey of complications associated with 21,676 operative hysteroscopies. Eur J Obstet Gynecol Reprod Biol. 2002;104:160–4.PubMedCrossRefGoogle Scholar
  126. 126.
    Lasmar RB, Xinmei Z, Indman PD, Celeste RK, Di Spiezio Sardo A. Feasibility of a new system of classification of submucous myomas: a multicenter study. Fertil Steril. 2011;95:2073–7.PubMedCrossRefGoogle Scholar
  127. 127.
    Campo S, Campo V, Gambadauro P. Short-term and long-term results of resectoscopic myomectomy with and without pretreatment with GnRH analogs in premenopausal women. Acta Obstet Gynecol Scand. 2005;84:756–60.PubMedCrossRefGoogle Scholar
  128. 128.
    Muzii L, Boni T, Bellati F, Marana R, Ruggiero A, Zullo MA, Angioli R, Panici PB. GnRH analogue treatment before hysteroscopic resection of submucous myomas: a prospective, randomized, multicenter study. Fertil Steril. 2010;94:1496–9.PubMedCrossRefGoogle Scholar
  129. 129.
    Kamath MS, Kalampokas EE, Kalampokas TE. Use of GnRH analogues pre-operatively for hysteroscopic resection of submucous fibroids: a systematic review and meta-analysis. Eur J Obstet Gynecol Reprod Biol. 2014;177:11–8.PubMedCrossRefGoogle Scholar
  130. 130.
    Fedele L, Vercellini P, Bianchi S, Brioschi D, Dorta M. Treatment with GnRH agonists before myomectomy and the risk of short-term myoma recurrence. Br J Obstet Gynaecol. 1990;97:393–6.PubMedCrossRefGoogle Scholar
  131. 131.
    Propst AM, Liberman RF, Harlow BL, Ginsburg ES. Complications of hysteroscopic surgery: predicting patients at risk. Obstet Gynecol. 2000;96:517–20.PubMedGoogle Scholar
  132. 132.
    Shveiky D, Rojansky N, Revel A, Benshushan A, Laufer N, Shushan A. Complications of hysteroscopic surgery: “beyond the learning curve”. J Minim Invasive Gynecol. 2007;14:218–22.PubMedCrossRefGoogle Scholar
  133. 133.
    Paschopoulos M, Polyzos NP, Lavasidis LG, Vrekoussis T, Dalkalitsis N, Paraskevaidis E. Safety issues of hysteroscopic surgery. Ann N Y Acad Sci. 2006;1092:229–34.PubMedCrossRefGoogle Scholar
  134. 134.
    Hamou J. Uterine adhesions. In: Hamou JE, Patrick JT, John JS, editors. Hysteroscopy and microhysteroscopy: text and atlas. New York: Appleton & Lange; 1991. p. 139–50.Google Scholar
  135. 135.
    The American Fertility Society classifications of adnexal adhesions, distal tubal occlusion, tubal occlusion secondary to tubal ligation, tubal pregnancies, müllerian anomalies and intrauterine adhesions. Fertil Steril. 1988;49:944–55.Google Scholar
  136. 136.
    Taskin O, Sadik S, Onoglu A, Gokdeniz R, Erturan E, Burak F, Wheeler JM. Role of endometrial suppression on the frequency of intrauterine adhesions after resectoscopic surgery. J Am Assoc Gynecol Laparosc. 2000;7:351–4.PubMedCrossRefGoogle Scholar
  137. 137.
    Shokeir TA, Fawzy M, Tatongy M. The nature of intrauterine adhesions following reproductive hysteroscopic surgery as determined by early and late follow-up hysteroscopy: clinical implications. Arch Gynecol Obstet. 2008;277:423–7.PubMedCrossRefGoogle Scholar
  138. 138.
    Touboul C, Fernandez H, Deffieux X, Berry R, Frydman R, Gervaise A. Uterine synechiae after bipolar hysteroscopic resection of submucosal myomas in patients with infertility. Fertil Steril. 2009;92:1690–3.PubMedCrossRefGoogle Scholar
  139. 139.
    Guida M, Acunzo G, Di Spiezio Sardo A, Bifulco G, Piccoli R, Pellicano M, Cerrota G, Cirillo D, Nappi C. Effectiveness of auto-crosslinked hyaluronic acid gel in the prevention of intrauterine adhesions after hysteroscopic surgery: a prospective, randomized, controlled study. Hum Reprod. 2004;19:1461–4.PubMedCrossRefGoogle Scholar
  140. 140.
    Yang JH, Chen MJ, Wu MY, Chao KH, Ho HN, Yang YS. Office hysteroscopic early lysis of intrauterine adhesion after transcervical resection of multiple apposing submucous myomas. Fertil Steril. 2008;89:1254–9.PubMedCrossRefGoogle Scholar
  141. 141.
    Metwally M, Watson A, Lilford R, Vandekerckhove P. Fluid and pharmacological agents for adhesion prevention after gynaecological surgery. Cochrane Database Syst Rev. 2006;2:CD001298.Google Scholar
  142. 142.
    Gerli S, Baiocchi G, Favilli A, Di Renzo GC. New treatment option for early spontaneous rupture of a postmyomectomy gravid uterus. Fertil Steril. 2011;96:e97–8.PubMedCrossRefGoogle Scholar
  143. 143.
    Parker WH, Einarsson J, Istre O, Dubuisson JB. Risk factors for uterine rupture after laparoscopic myomectomy. J Minim Invasive Gynecol. 2010;17:551–4.PubMedCrossRefGoogle Scholar
  144. 144.
    Pistofidis G, Makrakis E, Balinakos P, Dimitriou E, Bardis N, Anaf V. Report of 7 uterine rupture cases after laparoscopic myomectomy: update of the literature. J Minim Invasive Gynecol. 2012;19:762–7.PubMedCrossRefGoogle Scholar
  145. 145.
    Vassilevski Y, Danilov A, Ivanov Y, Simakov S, Gamilov T. Personalized anatomical meshing of human body with applications. In book Modeling the heart and the circulatory system. vol 14. Cham, Switzerland: Springer; 2015., p. 221–36.Google Scholar
  146. 146.
    Yushkevich PA, Piven J, Hazlett HC, Smith RG, Ho S, Gee JC, Gerig G. User-guided 3D active contour segmentation of anatomical structures: significantly improved efficiency and reliability. Neuroimage. 2006;31(3):1116–28.PubMedCrossRefGoogle Scholar
  147. 147.
    ITK-SNAP Medical Image Segmentation Tool. http://itksnap.org/.
  148. 148.
    Convert3D Tool. http://itksnap.org/c3d/.
  149. 149.
    Wu Z, Sullivan JM. Multiple material marching cubes algorithm. Int J Numer Meth Eng. 2003;58:189–207.CrossRefGoogle Scholar
  150. 150.
    Taubin G. A signal processing approach to fair surface design. In book Proceedings of the 22nd Annual Conf. on Comp. Graphics and Interactive Techniques, ACM, New York;1995. p. 351–8.Google Scholar
  151. 151.
    Vassilevski YuV, Vershinin AV, Danilov AA, Plenkin AV. Tetrahedral mesh generation in domains defined in CAD systems. In book Matrix methods and technology for solving large problems. Moscow: Institute of Numerical Mathematics, 2005; 21–32, (in Russian).Google Scholar
  152. 152.
    Rineau L, Yvinec M. A generic software design for Delaunay refinement meshing. Comp Geom Theory Appl. 2007;38:100–10.CrossRefGoogle Scholar
  153. 153.
    Danilov AA. Unstructured tetrahedral mesh generation technology. Comp Math Math Phys. 2010;50:139–56.CrossRefGoogle Scholar
  154. 154.
    Frey P, George PL. Mesh generation: application to finite elements. Paris/Oxford: Hermes Science; 2000.Google Scholar
  155. 155.
    Advanced Numerical Instruments 3D. http://sourceforge.net/projects/ani3d.
  156. 156.
    Danilov AA, Simakov SS, Vassilevski YV, Malvasi A, Ishchenko AI, Kovaleva AM, Mynbaev OA, Tinelli A. A mathematical model of myoma pseudocapsule. The NESA Days 2015. 18–20 September 2015. Berlin, Germany.Google Scholar
  157. 157.
    Danilov AA, Salamatova VYu, Simakov SS, Tinelli A, Malvasi A, Mynbaev OA, Mal’kov PG, Ishchenko AI, Kovaleva AM, Vassilevski YuV. Virtual mechanical soft tissue computational simulations of uterine scar after myomectomy. The NESA Days 2015. 18–20 September 2015. Berlin, Germany.Google Scholar
  158. 158.
    Babenko TI, Danilov AA, Simakov SS, Ryzhkov VV, Kovalev MI, Danilova NV, Mal’kov PG, Mynbaev OA. A virtual 3D model of uterine scar after caesarean section. V International conference on biotechnology and pharmaceutics ‘PhystechBIO’. 29–30 April 2015. Moscow Institute of Physics and Technology, Dolgoprudny, Russia.Google Scholar
  159. 159.
    Mynbaev OA, Simakov SS, Danilov AA, Kolobov AV, Mal’kov PG, Polyakov YuV, Kovalev MI, Ishchenko AIL, Tinelli A, Malvasi A, Melerzanov AV, Vassilevski YuV. Angiogenesis initiation and vascular network development during uterine fibroid formation and growth. V International conference on biotechnology and pharmaceutics ‘PhystechBIO’. 29–30 April 2015. Moscow Institute of Physics and Technology, Dolgoprudny, Russia.Google Scholar
  160. 160.
    Mazzon I, Favilli A, Grasso M, Morricone D, Di Renzo GC, Gerli S. Is ‘cold loop’ hysteroscopic myomectomy a better option for reproduction in women with diffuse uterine leiomyomatosis? A case report of successful repeated pregnancies. J Obstet Gynaecol Res. 2014; doi: 10.1111/jog.12548. [Epub ahead of print]PubMedGoogle Scholar
  161. 161.
    Camanni M, Bonino L, Delpiano EM, Ferrero B, Migliaretti G, Deltetto F. Hysteroscopic management of large symptomatic submucous uterine myomas. J Minim Invasive Gynecol. 2010;17:59–65.PubMedCrossRefGoogle Scholar
  162. 162.
    Leone FP, Calabrese S, Marciante C, Cetin I, Ferrazzi E. Feasibility and long-term efficacy of hysteroscopic myomectomy for myomas with intramural development by the use of non-electrical “cold” loops. Gynecol Surg. 2012;9:155–61.CrossRefGoogle Scholar
  163. 163.
    Butram VC, Reiter RC. Uterine Leiomyomata: etiology, symptomatology and management. Fertil Steril. 1981;36:433–45.CrossRefGoogle Scholar

Copyright information

© Springer International Publishing Switzerland 2018

Authors and Affiliations

  • Andrea Tinelli
    • 1
    • 2
    Email author
  • Ospan A. Mynbaev
    • 3
  • Daniele Vergara
    • 4
  • Silvia Di Tommaso
    • 5
  • Sandro Gerli
    • 6
  • Alessandro Favilli
    • 6
  • Ivan Mazzon
    • 7
  • Radmila Sparic
    • 8
    • 9
  • Marina Eliseeva
    • 10
  • Sergei S. Simakov
    • 11
  • Alexander A. Danilov
    • 12
    • 13
  • Antonio Malvasi
    • 14
  1. 1.Department of Gynecology and Obstetrics, Division of Experimental Endoscopic SurgeryImaging, Minimally Invasive Therapy and Technology, Vito Fazzi HospitalLecceItaly
  2. 2.Laboratory of Human PhysiologyMoscow Institute of Physics and Technology (State university)DolgoprudnyRussia
  3. 3.The Department of Obstetrics, Gynecology and Reproductive MedicinePeoples’ Friendship University of RussiaMoscowRussia
  4. 4.Department of Biological and Environmental Sciences and TechnologiesUniversity of SalentoVia MonteroniItaly
  5. 5.Division of Medical Genetics, Department of Biomedical Sciences and Human OncologyUniversità “AldoMoro”BariItaly
  6. 6.Department of Obstetrics and GynecologyUniversity of PerugiaPerugiaItaly
  7. 7.Unit of Gynecology and Obstetrics“Arbor Vitae” Centre, Clinica Nuova Villa ClaudiaRomeItaly
  8. 8.Clinic of Gynecology and ObstetricsClinical Center of SerbiaBelgradeSerbia
  9. 9.School of Medicine, University of BelgradeBelgradeSerbia
  10. 10.Department of Obstetrics and GynecologyPeoples’ Friendship University of RussiaMoscowRussia
  11. 11.Department of Applied MathematicsInternational Translational Medicine and Biomodelling Research Group, Moscow Institute of Physics and Technology (MIPT)MoscowRussia
  12. 12.Institute of Numerical MathematicsRussian Academy of SciencesMoscowRussia
  13. 13.Moscow Institute of Physics and Technology (MIPT)MoscowRussia
  14. 14.Department of Gynecology and ObstetricsSanta Maria Hospital, GVM Care and ResearchBariItaly

Personalised recommendations